0000899243-22-034463.txt : 20221028
0000899243-22-034463.hdr.sgml : 20221028
20221028183619
ACCESSION NUMBER: 0000899243-22-034463
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221027
FILED AS OF DATE: 20221028
DATE AS OF CHANGE: 20221028
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reed Joshua
CENTRAL INDEX KEY: 0001746541
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40657
FILM NUMBER: 221343346
MAIL ADDRESS:
STREET 1: C/O ALDEYRA THERAPEUTICS, INC.
STREET 2: 131 HARTWELL AVENUE, SUITE 320
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Omega Therapeutics, Inc.
CENTRAL INDEX KEY: 0001850838
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20 ACORN PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: (617) 949-4360
MAIL ADDRESS:
STREET 1: 20 ACORN PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-10-27
0
0001850838
Omega Therapeutics, Inc.
OMGA
0001746541
Reed Joshua
C/O OMEGA THERAPEUTICS, INC.
20 ACORN PARK DRIVE
CAMBRIDGE
MA
02140
0
1
0
0
Chief Financial Officer
Option (Right to Buy)
5.27
2022-10-27
4
A
0
55000
0.00
A
2032-10-26
Common Stock
55000
55000
D
The options vest and become exercisable as to 25% of the underlying shares on October 27, 2023 and as to 6.25% of the underlying shares upon the Reporting Person's completion of each three full months of continued service to the Issuer thereafter, such that the option will be fully vested and exercisable on October 27, 2026.
/s/ Barbara Chan as Attorney-in-Fact for Joshua Reed
2022-10-28